 Marking its biggest deal in nearly six years, Johnson Johnson JNJ , Financial announced on Tuesday it is buying Abiomed Inc. ABMD , Financial for 16.6 billion in a bid to boost its cardiovascular business even as its spins off its consumer health division. 